0001209191-12-027021.txt : 20120509
0001209191-12-027021.hdr.sgml : 20120509
20120509164007
ACCESSION NUMBER: 0001209191-12-027021
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120507
FILED AS OF DATE: 20120509
DATE AS OF CHANGE: 20120509
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139-4242
BUSINESS PHONE: 6165776000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wysenski Nancy
CENTRAL INDEX KEY: 0001294596
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 12826303
MAIL ADDRESS:
STREET 1: 2200 SUNBURST STREET
CITY: CHATSWORTH
STATE: CA
ZIP: 90401
4
1
doc4.xml
FORM 4 SUBMISSION
X0305
4
2012-05-07
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001294596
Wysenski Nancy
C/O VERTEX PHARMACEUTICALS INCORPORATED
130 WAVERLY ST
CAMBRIDGE
MA
02139
0
1
0
0
EVP, Chief Commercial Officer
Common Stock
2012-05-07
4
M
0
6797
33.82
A
43191
D
Common Stock
2012-05-07
4
M
0
12500
39.70
A
55691
D
Common Stock
2012-05-07
4
M
0
120000
39.70
A
175691
D
Common Stock
2012-05-07
4
M
0
3398
38.80
A
179089
D
Common Stock
2012-05-07
4
S
0
147695
54.50
D
31394
D
Common Stock
2012-05-08
4
M
0
9063
33.82
A
40457
D
Common Stock
2012-05-08
4
M
0
10196
38.80
A
50653
D
Common Stock
2012-05-08
4
M
0
18750
39.70
A
69403
D
Common Stock
2012-05-08
4
S
0
9063
59.19
D
60340
D
Common Stock
2012-05-08
4
S
0
10196
62.08
D
50144
D
Common Stock
2012-05-08
4
S
0
18750
63.52
D
31394
D
Stock Option
33.82
2012-05-07
4
M
0
6797
0.00
D
2010-10-14
2020-07-13
Common Stock
6897
29453
D
Stock Option
39.70
2012-05-07
4
M
0
12500
0.00
D
2010-03-09
2019-12-08
Common Stock
12500
87500
D
Stock Option
39.70
2012-05-07
4
M
0
120000
0.00
D
2011-05-23
2019-12-08
Common Stock
120000
180000
D
Stock Option
38.80
2012-05-07
4
M
0
3398
0.00
D
2011-05-03
2021-02-02
Common Stock
3398
50977
D
Stock Option
33.82
2012-05-08
4
M
0
9063
0.00
D
2010-10-14
2020-07-13
Common Stock
9063
20390
D
Stock Option
38.80
2012-05-08
4
M
0
10196
0.00
D
2011-05-03
2021-02-02
Common Stock
10196
40781
D
Stock Option
39.70
2012-05-08
4
M
0
18750
0.00
D
2010-03-09
2019-12-08
Common Stock
18750
68750
D
Transaction made pursuant to Ms. Wysenski's company approved trading plan under Rule 10b5-1.
David T. Howton, Attorney-In-Fact
2011-05-09